The
liver is the major organ of metabolism and is extremely vulnerable
to chronic stress. Lycopene (LYC) is a natural carotenoid with potent
antioxidant and chronic disease potential. However, whether LYC protects
against chronic restraint stress (CRS)-induced liver injury and the
underlying mechanisms remain unclear. In this study, rats were restrained
for 21 days for 6 h per day, with or without gavage of LYC (10 mg/kg).
Serum ALT (85.99 ± 4.07 U/L) and AST (181.78 ± 7.35 U/L)
and scores of liver injury were significantly increased in the CRS
group. LYC significantly promoted the nuclear translocation of Nrf2,
elevated the expression of antioxidant genes, and attenuated reactive
oxygen radicals (ROS) levels within the liver. Cellular thermal shift
assay (CETSA) and molecular docking results indicated that LYC competitively
binds to Keap1 with the lowest molecule affinity of −9.0 kcal/mol.
Moreover, LYC significantly relieved the hepatic endoplasmic reticulum
swelling and decreased the expression of endoplasmic reticulum stress
(ERS) hallmarks like GRP78, CHOP, and cleaved caspase-12. Meanwhile,
LYC also mitigated CRS-induced hepatocyte apoptosis. Interestingly,
every other day, the intraperitoneal injection of the Nrf2 inhibitor
brusatol (0.4 mg/kg) significantly counteracted the protective effect
of LYC. In conclusion, LYC protects against CRS-induced liver injury
by activating the Nrf2 signaling pathway, scavenging ROS, and further
attenuating ERS-associated apoptosis pathways.